2-Hydroxyglutarate or 2-HG is an oncometabolite produced to strikingly high levels by tumours harbouring somatic isocitrate dehydrogenase mutations (IDH-1 or IDH-2), such that it can be detected in the peripheral blood of patients. The gene discussed is IDH1; the disease is neoplasm.